Andrew Dellinger

Andrew Dellinger

Auto-generated profile, based on publicly available information

Andrew Dellinger

Elon University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Hepatology
Verified
Journal Article
Closed access
YLYi‐Ju Li
Yi‐Ju Li
EPElizabeth J. Phillips
Elizabeth J. Phillips
ADAndrew Dellinger
Andrew Dellinger
PNPaola Nicoletti
Paola Nicoletti
RSRyan Schutte
Ryan Schutte
TNThe Drug‐Induced Liver Injury Network
The Drug‐Induced Liver Injury Network

22 September 2022 in Journal of Hepatology
Verified
Journal Article
Closed access
NCNaga Chalasani
Naga Chalasani
YLYi-Ju Li
Yi-Ju Li
ADAndrew Dellinger
Andrew Dellinger
VNVictor Navarro
Victor Navarro
HBHerbert Bonkovsky
Herbert Bonkovsky
JHJay H. Hoofnagle
Jay H. Hoofnagle

8 August 2023 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PNPaola Nicoletti
Paola Nicoletti
ADAndrew Dellinger
Andrew Dellinger
YLYi-Ju Li
Yi-Ju Li
HBHuiman Barnhart
Huiman Barnhart
EPElizabeth J. Phillips
Elizabeth J. Phillips
FIfor the Drug Induced Liver Injury Network (DILIN) investigators
for the Drug Induced Liver Injury Network (DILIN) investigators
INTRODUCTION: To investigate human leukocyte antigen alleles associated with liver injury due to antiepileptic drugs (AEDs) in African Americans (AA). METHODS: In this study, 21 AA with AED drug-induced liver injury (DILI), 176 AA with DILI due to non-AEDs, and 5816 AA population controls were included. RESULTS: HLA-B*53:01 was significantly associated with aromatic AED-DILI (odds ratio: 4.52, 95% confidence interval: 2.42–8.44, P = 1.46 × 10−5). Phenytoin DILI showed the strongest association with HLA-B*53:01 (odds ratio: 9.17; 95% confidence interval: 3.61–23.28, P = 1.1 × 10−5). The HLA-B*53:01 allele was carried by 8 of 9 AA phenytoin DILI cases. DISCUSSION: HLA-B*53:01 is a significant risk factor of liver injury due to antiepileptics, particularly phenytoin, in AA.

10 April 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
JAJawad Ahmad
Jawad Ahmad
ADAndrew Dellinger
Andrew Dellinger
PNPaola Nicoletti
Paola Nicoletti
HBHuiman X. Barnhart
Huiman X. Barnhart
MGMarwan Ghabril
Marwan Ghabril
DNDrug-Induced Liver Injury Network
Drug-Induced Liver Injury Network
INTRODUCTION: Fluoroquinolones (FQ) have a favorable safety profile, but the risk of drug-induced liver injury (DILI) is well described. The aim of this study was to identify clinical features and HLA genetic variants associated with FQ-DILI in a large national registry. METHODS: Analysis of FQ-DILI cases enrolled in DILI Network between 2004 and 2022. HLA class I and II alleles were sequenced by the Illumina MiSeq platform. RESULTS: Sixty-one cases (32 ciprofloxacin, 22 levofloxacin, 7 moxifloxacin) were included. Clinical features between the 3 drugs were similar. The median duration of therapy was 7 (range 2–54) days, median age 53 (range 22–80) years, and 67% were female. Median latency to onset was 12 (range 2–1,370) days with 44% hepatocellular, 30% mixed, and 26% cholestatic pattern of liver injury. Median time to recovery was 65 days, but 13% had persistent injury at 6 months, 15% died (11% because of liver failure). Two HLA alleles were associated with an increased risk of liver injury: HLA-DQA1*03:01 (carriage frequency 38% in cases vs 19% in controls) and HLA B*57:01 (15% vs 6%). There was a significant difference between the combined carriage frequency of the 2 alleles of 48% in cases vs 24% controls ( P = 0.0001). No clinical characteristics or outcomes were associated with carriers compared with noncarriers. DISCUSSION: FQ DILI is a class effect that presents with a short latency, variable pattern of liver injury, and carries a significant risk of chronicity and mortality. There is a significant association with HLA-DQA1*03:01 and HLA B*57:01 .


10 June 2026 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
Lily DaraLily Dara
Lily Dara
PNPaola Nicoletti
Paola Nicoletti
CMChaudry Nasir Majeed
Chaudry Nasir Majeed
ADAndrew Dellinger
Andrew Dellinger
DKDavid E. Kleiner
David E. Kleiner
HBHerbert L. Bonkovsky
Herbert L. Bonkovsky